Fairvalue-Calculator Fairvalue-Calculator
EN DE

Cordlife GrouCordlife Group (CLIFF) Fair Value & Analysis

Healthcare · US · Market cap $38.6M

Price$0.1505
Fair Value$0.0400
Upside-73.4%
Quality95/100
Evidence: Low Range $0.0300 – $0.0500

Fair value as of: Jun 26, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Cordlife GrouCordlife Group (CLIFF) currently trades at $0.1505, while our model-based Fair Value estimate is $0.0400 — implying the stock looks roughly 73.4% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

About the company

Cordlife GrouCordlife Group Limited, an investment holding company, provides cord blood banking services in Singapore, Hong Kong, India, Malaysia, the Philippines, and internationally. It operates in two segments, Banking and Diagnostics. The Banking segment collects, processes, banks, and tests biological materials, such as cord blood, lining, and tissue samples. The Diagnostics segment offers diagnostic testing services, such as newborn genetic and metabolic screenings; pediatric vision and ear screenings; pediatric allergen test; and genetic talent test services. The company also provides corneal lenticule banking, and lifestyle genetic screening services for adults. In addition, it offers life sprouts, medical laboratory, marketing, and property investment services, as well as medical and pharmaceutical research and development and consulting services. Cordlife Group Limited was incorporated in 2001 and is based in Singapore.

Open the full interactive analysis →

Similar stocks

Thermo Fisher Scientific Inc (TMO) -34% Danaher Corporation (DHR) -37% WuXi AppTec Co (WUXAY) +35% IDEXX Laboratories, Inc (IDXX) -54% Lonza Group (LZAGY) -74% Agilent Technologies, Inc (A) -50%

Frequently asked questions

Is Cordlife GrouCordlife Group (CLIFF) undervalued?
As of Jun 26, 2026, our model estimates a fair value of $0.0400 versus a price of $0.1505 — about −73% (overvalued). Model-based estimate, not financial advice.
What is the fair value of CLIFF?
Our 21-model fair value for Cordlife GrouCordlife Group is $0.0400 (as of Jun 26, 2026), built from audited fundamentals. The current price is $0.1505.
What is the quality score of CLIFF?
Cordlife GrouCordlife Group has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.